Intraoperative Molecular Imaging of Lung Cancer: A Review.

Natalie S Lui, Sunil Singhal

Open access · greenAbstract readReview

In one paragraph

Review in Surgical oncology clinics of North America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.5field-weighted citation impact, top 35% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

Comparison of Near-Infrared Imaging Agents Targeting the PTPmu Tumor Biomarker.Molecular imaging and biology · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Natalie S LuiDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, 300 Pasteur Drive, Falk Building, Stanford, CA 94305, USA. Electronic address: natalielui@stanford.edu.

Sunil SinghalDivision of Thoracic Surgery, Translational Research, Department of Surgery, University of Pennsylvania, 3400 Civic Center Boulevard, 14th Floor, PCAM South Tower, Philadelphia, PA, USA.

Stanford University · US

Funding

Shared Resource - Core A: Administrative CoreP01CA254859 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Sunil Singhal · 2022 to 2026

$10.0M

NCI NIH HHS P01 CA254859

6 · The paper itself

Abstract

Intraoperative molecular imaging shows great promise in the surgical treatment of lung cancer, in particular tumor localization, margin assessment, identification of additional nodules, and even potentially lymph node assessment. Advances in imaging agents and fluorescence surgical cameras will be the key. Although no imaging agent is currently Food and Drug Administration approved, targeted, near-infrared agents such as OTL38 are in phase III trials.

Indexed as

Lung NeoplasmsHumansLymph NodesMolecular ImagingFluorescence imagingIndocyanine greenIntraoperative molecular imagingOTL38Panitumumab-IRDye800Thoracic surgery

Identifiers

PMID36243501

DOI10.1016/j.soc.2022.06.006

PMCPMC12424047

OpenAlexW4297310871

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.